L248M: The dominant L248M APTX mutant was identified in AOA1 patients with severe clinical phenotype presenting early disease onset and a progressive ataxic syndrome with cerebellar atrophy, mental retardation, and epilepsy (Table 1) (Castellotti et al, 2011). Here, APTX is linked to epilepsy.